CBS 2019
CBSMD教育中心
首页
CBS 2019
关于CBS
会议通知
会议组织
主办单位
南京市心血管病医院
亚洲分叉病变俱乐部
南京医科大学附属南京医院
南京市第一医院医学发展医疗救助基金会
协办单位
中华医学会心血管病学分会
国家卫生健康委能力建设和继续教育心血管病学专家委员会（CBCEC）
美国心血管造影和介入学会
亚洲心脏学会
北京合众关爱心脏健康基金会
联系我们
境内代表注册管理:
彭红娟 ：
+86-13913895477
徐海梅 ：+86-13914736846
cbsnj@cbsmd.cn
境外代表注册管理:
林玲 ： +86 (25) 52271398
+86-13951884596
cbs@cbsmd.cn
病例征集管理:
赵莹莹 ：+86-13815408517
sub@cbsmd.cn
地址：
江苏省南京市秦淮区长乐路68号，南京市心血管病医院9号楼905区心内科办公室
210006
主席团
主席团
大会主席
联合主席
教育中心
教育中心
• 线上教育 （ 注册后可使用个人定义界面搜集科研图书馆文献、下载教育资源、参与在线病例讨论。）
• 教育资源
• 科研动态
科研图书馆
科研图书馆
科研文章
> 急性冠脉综合征
> 动脉粥样硬化性心血管疾病
> 分叉支架
> 心脏肿瘤科
> 充血性心力衰竭
> 双重抗血小板治疗持续时间
> 药物涂层球囊
> 血流储备分数
> 血管内超声指导
> 光学相关断层扫描
> 肺动脉高压
> 旋磨术
> 血流动力学与动脉粥样硬化
> 左主干支架
> 经导管主动脉瓣置换
> 经皮左心耳封堵
> 二尖瓣/三尖瓣瓣膜
> 推荐文献
荐读文献
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic
ACC临床简报:新型冠状病毒对心脏的影响(2019-nCoV)
SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography and Intervention
Guideline | By Roffi M, Patrono C, ESC Scientific Document Group.
Original Research | By Prejean SP, Din M, Reyes E et al.
In this Guidelines in Review, we review side-by-side the recommendations provided by the 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. We review the recommendations for imaging in the evaluation of patients with possible ACS f...
Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines
Guideline | By Galiè N, Humbert M, ESC Scientific Document Group.
What's new in the Fourth Universal Definition of Myocardial infarction?
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Original Research | By DB Mark, PA Cowper, KJ Anstrom et al.
BACKGROUND - The GUIDE-IT (GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure) trial prospectively compared the efficacy of an N-terminal pro–B-type natriuretic peptide (NT-proBNP)–guided heart failure treatment strategy (target NT-proBNP level <1,000 pg/ml) with optimal medical therapy alone in high-risk patients with heart failure and reduced ejection fraction. When ...
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Original Research | By DB Mark, PA Cowper, KJ Anstrom et al.
BACKGROUND - The GUIDE-IT (GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure) trial prospectively compared the efficacy of an N-terminal pro–B-type natriuretic peptide (NT-proBNP)–guided heart failure treatment strategy (target NT-proBNP level <1,000 pg/ml) with optimal medical therapy alone in high-risk patients with heart failure and reduced ejection fraction. When ...
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Original Research | By Felker GM, Ahmad T, Anstrom KJ et al.
Review Article | By Ibrahim NE, Januzzi JL Jr.
PURPOSE OF REVIEW - Biomarker-guided management of patients with chronic heart failure with reduced ejection fraction (HFrEF) remains controversial. RECENT FINDINGS - Biomarkers have established roles for diagnosis and prognostication in HF. Pilot data suggested that use of natriuretic peptides might be helpful to guide HF care. The recent Guiding Evidence-Based Therapy Using Biomarker Intens...
English
CBS 2019
CBS 2019 主席团
教育中心
科研动态
